Menu Our position on Learn more about our views and our practices across a range of issues that are important to GSK, our patients and consumers, and our stakeholders. Access to medicines and vaccines Patents and access to medicines in developing countries PDF - 188.1KB Technology transfer, capacity building and developing countries PDF - 232.7KB Tiered pricing and vaccines PDF - 150.2KB Civil society organisations and vaccine procurement PDF - 152.3KB Tackling Global Health Challenges PDF - 199.8KB Treatment Use of Unlicensed Medicines PDF - 156.9KB Product donations PDF - 151.7KB Responsible science Our Approach to Clinical Trials PDF - 152.2KB Cloning and Stem Cell Technologies PDF - 38.7KB The convention on biological diversity PDF - 239.9KB Public disclosure of clinical research PDF - 175.1KB The care, welfare and treatment of animals PDF - 42.2KB Pharmacovigilance PDF - 147.8KB Falsified and Substandard Healthcare products PDF - 165.6KB Valuing innovation Incremental innovation PDF - 177.4KB Compulsory licensing PDF - 195.1KB Evergreening PDF - 139.7KB A disclosure requirement in patent law PDF - 196.4KB Regulatory data protection PDF - 189.2KB Health security Pandemic preparedness PDF - 270.4KB Combating antimicrobial resistance PDF - 208.8KB Environment and nature impact Hazardous chemicals management PDF - 178.2KB Genetically modified micro-organisms and Environment, Health and Safety (EHS) PDF - 187.4KB Nanotechnology PDF - 161.2KB Respiratory Products and Global Warming PDF - 132.6KB Pharmaceuticals in environment PDF - 160.7KB The impact of climate change on health PDF - 164.2KB Climate Change and GSK’s Operations PDF - 152.0KB Water stewardship PDF - 132.5KB Deforestation-free sourcing PDF - 243.7KB Environmental management PDF - 129.9KB Business integrity Engagement with patient organisations PDF - 317.6KB Conflict minerals PDF - 193.7KB Competitiveness and investment criteria PDF - 182.4KB Human rights PDF - 144.6KB Marketing practices and scientific engagement PDF - 155.8KB Safeguarding personal information PDF - 216.7KB Tax strategy PDF - 298.1KB Political Advocacy PDF - 168.4KB Working with third parties PDF - 252.4KB Lethal Injections PDF - 79.0KB Find out more about us GSK Leadership Team The GSK Leadership Team manages our activities, and each member is responsible for a specific part of the business Codes and standards Find out more about the GSK Code of Conduct and our Anti-Bribery and Corruption programme Operating responsibly Our values and expectations are at the heart of everything we do RSS Other GSK websites Market website selector GSKPro for healthcare professionals GSK Study Register Quick links COVID-19 response Behind the science About us Products Careers Investors Media Research and development Responsibility Accessibility/legal Accessibility Terms of use Cookie policy Privacy notice Modern Slavery Act statement 2020 PDF - 191.4KB Sitemap Contact us Contact us Partnerships Report a possible side effect Business to business Supplier website Business to business This is our global website, intended for visitors seeking information on GSK’s worldwide business. Our market sites can be reached by visiting our market selector. © 2001-2021 GlaxoSmithKline plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GlaxoSmithKline plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. We use cookies GSK values your privacy and your trust is important to us. We use cookies to enhance your website experience. Some cookies are necessary to run the website. Others are optional: performance cookies show us how you use our website and features; functional cookies remember your preferences; and advertising cookies help us share relevant content.Cookie Policy Show detail ❮ OPT OUT ACCEPT ALL